BioCritica

About:

BioCritica develops and commercializes critical care products for the healthcare industry.

Top Investors: Novaquest Capital Management, Care Capital

Description:

BioCritica is a biotechnology company focused on meeting the critical care needs of patients and clinicians in the hospital market. In addition to Xigris for the treatment of severe sepsis, BioCritica is developing a pipeline of other products. Their mission is to develop and commercialize products that make a dramatic improvement in people's lives.

Total Funding Amount:

$25M

Headquarters Location:

Indianapolis, Indiana, United States

Founded Date:

2011-01-01

Contact Email:

bdev(AT)biocritica.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2011-05-25

IPO Status:

Private

Industries: